Examining Whether Genetic Variants Moderate the Skeletal Effects of Selective Serotonin Reuptake Inhibitors in Older Adolescents and Young Adults

被引:0
作者
Ezenwabachili, Ifeoma [1 ]
Shultz, Emira Deumic [2 ]
Mills, James A. A. [2 ]
Ellingrod, Vicki [3 ]
Calarge, Chadi A. A. [4 ,5 ]
机构
[1] Baylor Coll Med, Houston, TX 77030 USA
[2] Univ Iowa, Dept Psychiat, Iowa City, IA USA
[3] Univ Michigan, Coll Pharm, Ann Arbor, MI USA
[4] Baylor Coll Med, Menninger Dept Psychiat & Behav Sci, 1102 Bates Ave,Suite 790, Houston, TX 77030 USA
[5] Baylor Coll Med, Dept Pediat, 1102 Bates Ave,Suite 790, Houston, TX 77030 USA
关键词
pharmacogenetics; antidepressants; serotonin; children; bone mass; BONE-MINERAL DENSITY; 2A RECEPTOR GENE; TRANSPORTER GENE; VNTR POLYMORPHISM; REFERENCE CURVES; FRACTURE RISK; EXPRESSION; ASSOCIATION; CHILDREN; DEPRESSION;
D O I
10.1089/cap.2023.0007
中图分类号
R72 [儿科学];
学科分类号
100202 ;
摘要
Objective: To examine whether serotonin (5-HT) related genetic variants moderate the effects of selective serotonin reuptake inhibitors (SSRIs) on skeletal outcomes.Methods: Trabecular bone mineral density (BMD) at the radius, lumbar spine (LS) BMD, total body less head (TBLH) bone mineral content (BMC) and markers of bone metabolism (osteocalcin, C-terminal telopeptide of type I collagen [CTX-1], and bone specific alkaline phosphatase to CTX-1 ratio) were examined in an observational study, enrolling 15- to 20-year-old participants, unmedicated or within a month of SSRI initiation. Variants in HTR1A (rs6295), HTR1B (rs6296), HTR1D (rs6300), HTR2A (rs6311 and rs6314), HTR2B (rs6736017), and the serotonin transporter intron 2 variable number tandem repeat (STin2 VNTR) were genotyped. Linear mixed-effects regression analysis examined associations between SSRI use, genetic variants, and skeletal outcomes.Results: After adjusting for relevant covariates, rs6295 CC and GC genotypes in 262 participants (60% female, mean & PLUSMN; SD age = 18.9 & PLUSMN; 1.6 years) were significantly associated with higher LS BMD compared to the GG genotype. Rs6311 GG SSRI users had greater LS BMD compared to nonusers (& beta; = 0.18, p = <0.0001). Female SSRI users with the combination of rs6295 CC+GC and rs6311 GG genotypes had greater LS BMD than female SSRI nonusers (& beta; = 0.29, p < 0.0001). SSRI users with the rs6295 GG genotype had higher trabecular BMD compared to nonusers (& beta; = 3.60, p = 0.05). No significant interactions were found for TBLH BMC or bone turnover markers. After correcting for multiple comparisons, none of the results retained significance.Conclusions: In older adolescents and young adults, HTR1A (rs6295) and HTR2A (rs6311) variants may moderate the effect of SSRIs on BMD. Sex differences may exist and require further examination. Further research with larger sample sizes is needed to confirm our preliminary findings.
引用
收藏
页码:260 / 268
页数:9
相关论文
共 65 条
  • [1] Evaluation of the effect of selective serotonin reuptake inhibitors on bone mineral density: an observational cross-sectional study
    Ak, E.
    Bulut, S. D.
    Bulut, S.
    Akdag, H. A.
    Oter, G. B.
    Kaya, H.
    Kaya, O. B.
    Sengul, C. B.
    Kisa, C.
    [J]. OSTEOPOROSIS INTERNATIONAL, 2015, 26 (01) : 273 - 279
  • [2] American Psychiatric Association A, 1994, DIAGNOSTIC STAT MANU, DOI [10.1176/appi.books.9780890425596, DOI 10.1176/APPI.BOOKS.9780890425596]
  • [3] Interaction between 5-HTTLPR and 5-HT1B genotype status enhances cerebral 5-HT1A receptor binding
    Baldinger, Pia
    Kraus, Christoph
    Rami-Mark, Christina
    Gryglewski, Gregor
    Kranz, Georg S.
    Haeusler, Daniela
    Hahn, Andreas
    Spies, Marie
    Wadsak, Wolfgang
    Mitterhauser, Markus
    Rujescu, Dan
    Kasper, Siegfried
    Lanzenberger, Rupert
    [J]. NEUROIMAGE, 2015, 111 : 505 - 512
  • [4] Quality of life impairment in generalized anxiety disorder, social phobia, and panic disorder
    Barrera, Terri L.
    Norton, Peter J.
    [J]. JOURNAL OF ANXIETY DISORDERS, 2009, 23 (08) : 1086 - 1090
  • [5] Beck A. T., 1967, Depression: Clinical, experimental and theoretical aspects
  • [6] AN INVENTORY FOR MEASURING CLINICAL ANXIETY - PSYCHOMETRIC PROPERTIES
    BECK, AT
    BROWN, G
    EPSTEIN, N
    STEER, RA
    [J]. JOURNAL OF CONSULTING AND CLINICAL PSYCHOLOGY, 1988, 56 (06) : 893 - 897
  • [7] Converging Evidence for the Association of Functional Genetic Variation in the Serotonin Receptor 2a Gene With Prefrontal Function and Olanzapine Treatment
    Blasi, Giuseppe
    De Virgilio, Caterina
    Papazacharias, Apostolos
    Taurisano, Paolo
    Gelao, Barbara
    Fazio, Leonardo
    Ursini, Gianluca
    Sinibaldi, Lorenzo
    Andriola, Ileana
    Masellis, Rita
    Romano, Raffaella
    Rampino, Antonio
    Di Giorgio, Annabella
    Lo Bianco, Luciana
    Caforio, Grazia
    Piva, Francesco
    Popolizio, Teresa
    Bellantuono, Cesario
    Todarello, Orlando
    Kleinman, Joel E.
    Gadaleta, Gemma
    Weinberger, Daniel R.
    Bertolino, Alessandro
    [J]. JAMA PSYCHIATRY, 2013, 70 (09) : 921 - 930
  • [8] Serotonin transporter and receptor expression in osteocytic MLO-Y4 cells
    Bliziotes, M.
    Eshleman, A.
    Burt-Pichat, B.
    Zhang, X. -W.
    Hashimoto, J.
    Wiren, K.
    Chenu, C.
    [J]. BONE, 2006, 39 (06) : 1313 - 1321
  • [9] Neurotransmitter action in osteoblasts: Expression of a functional system for serotonin receptor activation and reuptake
    Bliziotes, MM
    Eshleman, AJ
    Zhang, XW
    Wiren, KM
    [J]. BONE, 2001, 29 (05) : 477 - 486
  • [10] The Effect of Depression, Generalized Anxiety, and Selective Serotonin Reuptake Inhibitors on Change in Bone Metabolism in Adolescents and Emerging Adults
    Calarge, Chadi A.
    Mills, James A.
    Janz, Kathleen F.
    Burns, Trudy L.
    Schlechte, Janet A.
    Coryell, William H.
    Zemel, Babette S.
    [J]. JOURNAL OF BONE AND MINERAL RESEARCH, 2017, 32 (12) : 2367 - 2374